Chlamydia
著者
書誌事項
Chlamydia
Plenum Medical Book Co., c1989
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Bibliography: p. 295-357
Includes index
内容説明・目次
内容説明
During recent decades, it has been firmly documented that chlamydiae are com- mon and important pathogens in humans and animals. In humans, chlamydiae are known to cause trachoma (which is still one of the major blinding diseases in the world) and are also one of the most common etiological agents of sexually transmitted diseases and the sequelae thereof, such as infertility. In the last few years, it has also become evident that chlamydiae, i.e., the so-called TWAR agents, are common respiratory tract pathogens. Chlamydiae are also important pathogens in birds and lower mammals, in whom they cause a variety of infectious conditions, a spectrum which has in- creased every year. Some of these infections occur as zoonoses, e.g., psit- tacosis/ornithosis and, as recently discovered, abortion. Know ledge of the molecular biology and immunobiology of chlamydiae has expanded rapidly during recent years. Insight into the pathophysiology of chla- mydial infections has also increased, and new methods for the diagnosis of chlamydial infections have been introduced. The importance of establishing control and preventive programs for chla- mydial infections has become obvious in order to combat the present chlamydial epidemic. We hope that this book can usefully serve those who want to increase their general knowledge of Chlamydia and that it can act as a handbook and reference source for those involved in chlamydial research as well as for those working with chlamydial infections in medical and veterinary clinical disciplines, includ- ing clinical laboratories.
目次
I. Introduction.- 1. A Historical Outline.- Clinical Spectrum of Chlamydial Diseases.- Diagnosis of Chlamydial Infections.- Molecular Biology of Chlamydiae.- Landmarks in Chlamydiology.- The Future.- II. Microbiology, Immunopathology, and Animal Models.- 2. The Chlamydiae.- Classification.- Morphology and Replication.- Antigenic Composition.- Genetics.- 3. Pathology of Chlamydial Infections.- Cytology.- Histopathology.- 4. Immune Response.- Humoral and Local Immune Response.- Cell-Mediated Immune Response.- 5. Animal Models.- Guinea Pigs.- Mice.- Cats.- Monkeys.- Koalas.- III. Diagnosis.- 6. Diagnosis of Chlamydial Infections.- Isolation.- Host-Parasite Interactions.- Cell Lines and Comparison of Cell Treatments.- Tissue Culture Medium.- Centrifugation.- Vials/Microtiter Plates.- Sampling Sites.- Blind Passages.- Detection of Chlamydial Inclusions.- Incubation.- Sensitivity of Culture.- Factors Interfering with Isolation of Chlamydia trachomatis.- Toxic Sampling Swabs.- Inhibitory Body Fluid Constituents.- Toxic Glass and Plastic Wares.- Transport and Storage Conditions.- Microbial Superinfection.- Diagnosis of Chlamydial Infections by Direct Analyses of Clinical Samples.- Detection of Chlamydial Particles by Staining Procedures.- Giemsa Staining.- Iodine Staining.- Papanicolaou Staining.- Immunoperoxidase Staining.- Immunofluorescence Tests.- Detection of Chlamydial Antigen.- Enzyme Immunoassays.- Other Immunoassays.- Electron Microscopy.- Detection of Chlamydial Nucleic Acid.- General Remarks on the Clinical Value of "Rapid" Diagnostic Tests.- Serology.- Complement Fixation.- Microimmunofluorescence.- Inclusion Immunofluorescence.- Enzyme Immunoassays.- Other Tests.- Occurrence of Antichlamydial Antibodies, and General Remarks on the Interpretation of Serological Chlamydial Tests.- IV. Antibiosis and Vaccines.- 7. Antibiotic Susceptibility Testing.- 8. Susceptibility of Chlamydiae to Different Antimicrobials.- Overview.- Sulfonamides.- Penicillins.- Cephalosporins.- Tetracyclines.- Macrolides.- Rifampins.- Quinolones.- Clindamycin.- Some Drugs with Poor Activity against C. trachomatis.- 9. Body Fluid Constituents with Antichlamydial Activity.- 10. Persistence, Relapses, and Reinfections of Chlamydial Infections.- 11. Vaccines.- V. Chlamydia trachomatis Infections.- 12. Trachoma.- Epidemiology.- Immunopathology.- Staging and Clinical Diagnosis.- Clinical Findings.- Laboratory Diagnosis.- Prevention and Treatment.- 13. Genital and Associated Infections in the Male.- Nongonococcal Urethritis (NGU) and Postgonococcal Urethritis (PGU).- Epidemiology.- Diagnosis of Urethritis.- Clinical Findings.- Diagnosis of Chlamydial Urethritis.- Treatment.- Sequelae.- Epididymitis.- Epidemiology.- Clinical Findings.- Diagnosis.- Treatment.- Sequelae.- Prostatitis.- Proctitis.- 14. Genital Tract and Associated Infections in the Female.- Acute Urethral Syndrome.- Epidemiology.- Clinical Findings.- Diagnosis.- Therapy.- Vaginitis/Vaginosis.- Mucopurulent Cervicitis.- Epidemiology.- Diagnosis of Cervicitis.- Histopathology.- Diagnosis of Chlamydial Cervicitis.- Therapy.- Endometritis.- Epidemiology.- Histopathology.- Chlamydial Endometritis.- Correlation between Endometritis and Salpingitis.- Diagnosis.- Therapy.- Salpingitis.- Epidemiology.- Diagnosis of Salpingitis.- Clinical Findings.- Diagnosis of Chlamydial Salpingitis.- Therapy.- Sequelae.- Chronic or Subclinical Pelvic Inflammatory Disease.- 15. Infertility.- Epidemiology.- Pathogenetic Mechanisms.- Role of Chlamydia trachomatis Infections.- 16. Periappendicitis.- Epidemiology.- Clinical Findings.- Diagnosis.- Therapy.- 17. Peritonitis and Perihepatitis.- Epidemiology.- Immunopathology.- Diagnosis.- Therapy.- 18. Adverse Pregnancy Outcome.- 19. Postpartum Endometritis.- 20. Tubal (Ectopic) Pregnancy.- 21. Contraceptive Use and Infection by Chlamydia trachomatis.- 22. Concomitant Infection with Chlamydia trachomatis, Neisseria gonorrhoeae, and Other Genital Pathogens, and Treatment of Mixed Infections.- 23. Reiter's Syndrome.- Epidemiology.- Chlamydial Infection.- Clinical Findings.- Diagnosis.- Therapy.- 24. Lymphogranuloma Venereum.- Epidemiology.- Pathology.- Clinical Findings.- Diagnosis.- Therapy.- 25. Neonatal Infections.- Conjunctivitis.- Epidemiology.- Clinical Findings.- Diagnosis.- Prophylaxis.- Treatment.- Sequelae.- Pneumonia.- Epidemiology.- Clinical Findings.- Diagnosis.- Treatment.- Sequelae.- Various Other Neonatal Infections.- 26. Infections in Childhood.- Seroepidemiology.- Clinical Findings.- 27. Chlamydial Infections in Adolescence.- Epidemiology.- Diagnosis.- Prophylaxis.- 28. Sexual Abuse of Children.- 29. Ocular Nontrachoma Infections in Adults.- Epidemiology.- Clinical Findings.- Diagnosis.- Treatment.- Sequelae.- 30. Chlamydia trachomatis Respiratory Tract Infections in Adults.- 31. Disseminated Infections with Chlamydia trachomatis.- 32. Prevention and Control of Genital Chlamydial Infections.- Magnitude of the Problem.- Costs.- Epidemiological Markers.- Contraceptives Influencing Chlamydial Epidemiology.- Contact Tracing and Partner Treatment.- Screening Programs.- Efficiency of Laboratory Tests.- Preventive Measures.- VI. Chlamydia psittaci Infections.- 33. Chlamydia psittaci Infections in Humans.- Psittacosis/Ornithosis.- Epidemiology.- Clinical Findings.- Diagnosis.- Therapy.- Placentitis and Abortion.- 34. Chlamydia psittaci Infection in Birds.- Epidemiology.- Clinical Findings.- Treatment.- 35. Chlamydia psittaci Infection in Mammals 271.- Horses.- Cattle.- Pigs.- Goats.- Sheep.- Cats.- Dogs.- Koalas.- 36. TWAR Infections.- Epidemiology.- Clinical Findings.- Diagnosis.- Treatment.- References.
「Nielsen BookData」 より